Document is current
Any future updates will be listed below
-
Authors
Pasternack, Helen
Kuempers, Christiane
Deng, Mario
Watermann, Iris
Olchers, Till
Kuehnel, Mark
Jonigk, Danny
Kugler, Christian
Stellmacher, Florian
Goldmann, Torsten
Kirfel, Jutta
Ammerpohl, Ole
Perner, Sven
Reck, Martin
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim Pharma GmbH
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
- License Information
-
More Information
Article History
Received: 20 November 2020
Accepted: 31 March 2021
First Online: 5 May 2021
Competing interests
: Martin Reck received honoraria for lectures and consultancy from: Abbvie, Amgen, AstraZeneca, Boehringer-Ingelheim, BMS, Celgene, Lilly, Merck, MSD, Novartis, Pfizer and Roche. The other authors declare no potential conflict of interest. The work was funded by Boehringer Ingelheim Pharma GmbH & Co. KG without having any role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.
